Our 2023 Wilms Tumor and Rhabdomyosarcoma Nanocourse, scheduled for August 7-11th, still has four spots available for Rhabdomyosarcoma families. If you are interested in learning more about this intensive research experience visit: cc-tdi.org/nanocourse/
It is with grieving hearts that we announce the passing of our beloved Board Member Richard Levick. Richard was a staunch advocate of our mission and a dear friend. Charles shares his personal thoughts here: cc-tdi.org/the-passing-of-ou… #cctdi #childhoodcancerresearch #levick
Thank you @StarrChildrens for your support! We really appreciate your partnership in our research mission. #childhoodcancerresearch #cctdi #givingbackchildhood
cc-TDI would like to extend our support to all of those effected by childhood cancer. We are continuing to research in your honor so that one-day all childhood cancers are universally survivable. #internationalchildhoodcancerday #childhoodcancer #cctdi
We are thrilled to recognize the Megan's Mission Foundation for their recent $100,000 grant award supporting rhabdomyosarcoma research at cc-TDI.
A link to our press release can be found here: cc-tdi.org/megans-mission-aw… #rhabdomyosarcomaresearch
Wishing you all love and comfort this Valentines Day! Still struggling to find a meaningful last-minute gift for you loved one? Consider giving your heart to cc-TDI by making a donation in support of our research mission! cc-tdi.org #givingbackchildhood #cctdi
cc-TDI is hiring and Executive Director! Visit: cc-tdi.org/were-hiring-an-ex… to learn more and apply. #givingbackchildhood #cctdi #childhoodcancerresearch #nonprofit #executivedirectorsearch
Thank you to Shelby Sallee for nominating us to be a recipient of FCM Cares’ Holiday Giveback in which $3,228 was raised in support of cancer research. Shelby designated us in memory of her sister Rachel who passed in 2007 from rhabdomyosarcoma.
#childhoodcancerresearch #cctdi
We're excited to share our microscopic computed tomography (microCT) experts with the CLEE “sea creature” science program at @PortlandStateUn. We have published in this area lightly (pubmed.ncbi.nlm.nih.gov/1828…), but working with Annie and Jason take us to a deeper level. #cctdi
We recently recieved a $100,000 grant to further study Ewing sarcoma treatment options thanks to generous support from Golf Fights Cancer. This award, honoring Pete Fox, allows us to continue addressing a pressing need in relapsed Ewing sarcoma patients. #thankyou #ewingsarcoma
Megan's Mission Coffee is now available in K cups thanks to our friends at Live Life Coffee Beans! $5 of each bag (or box) supports rhabdo research at cc-tdi in memory of Megan! livelifecoffeebeans.com/prod…
Thank you @LylaNFoundation for their $100,000 grant supporting #DIPG research. This award funds the development of an antibody-drug conjugate (ADC) for DIPG, a universally fatal childhood brain cancer accounting for roughly 16% of pediatric central nervous system tumors.
Thank you to our newest corporate partner @SolutionStreet for their support of our childhood cancer research mission. We're grateful to be named their charity of choice for 2023! #cctdi #givingbackchildhood #childhoodcancerresearch
Make a year-end gift that truly matters. Our current blog post has a heartfelt parents perspective on supporting cc-TDI's mission. A link to the post can be found here: cc-tdi.org/your-support-matt… Thank you to Amy for allowing us to highlight your story. #cctdi
Today our collaborator Tristan Cates from @ChampionsOncol1 visited. Champions Oncology and their team (Iman Habib, and now Stefano Cairo) have done so much to help us develop clinical trial concepts from preclinical testing partnerships. #childhoodcancer #cctdi
Exciting progress is being made at our new lab! This week another big transformation will occur when drywall is installed. Thank you @rhconstco and @ZGFArchitects for their unwavering leadership and support! #MovingTheFuture #cctdi #childhoodcancerresearch
Today is #GIVINGTUESDAY, will you join the movement?
We're asking you to join us TODAY towards raising $10,000 for our new laboratory. All gifts make a lasting impact on our research. Thank you for allowing our team to continue our mission! cc-tdi.kindful.com/?campaign…
We’re thrilled to announce exciting progress on our Myoepithelial Carcinoma Biology & EWSR1 Orphan Cancers Drug Discovery Research Program! cc-tdi.org/mec-biology-and-d…
For additional information on MEC and how you can get involved visit: curemec.org.
#curemec #cctdi
Can you be the hero of this story?
Our amazing IVIS-3D has just reached the end of it’s useful life! Can you help us replace the instrument? cc-tdi.kindful.com/?campaign…
With this critical instrument, more drugs will be validated to move to human clinical trials - faster! #cctdi
Join Dr. Keller and worldwide collaborators illuminating the role of SMARCA2/4 in childhood alveolar rhabdomyosarcoma by targeted protein degradation with ACBI1. opnme.com/online-seminar/sma…






















